Suppr超能文献

[维生素B6在治疗患有遗传性代谢病的儿童中的作用]

[Role of vitamin B6 in treating children with hereditary metabolic pathology].

作者信息

Barashnev Iu I, Rozova I N, Semiachkina A N

出版信息

Vopr Pitan. 1979 Jul-Aug(4):32-40.

PMID:483728
Abstract

Possibilities of vitamin B6 treatment of patients with hereditary pathology of metabolism are discussed. Special attention is paid to the vitamin B6-dependent conditions characterized by elevated pyridoxine requirements. High pyridoxine doses were successfully used for the treatment of patients with hereditary vitamin B6-dependent xanthurenuria under the control of renal excretion of tryptophan metabolites (xanthurenic and kynurenic acids, kynurenin, N1-methylnicotinamide) and 4-pyridoxic acid. Interrelation was traced between the severity of the disease and the necessary pyridoxine doses. Patients with the most pronounced clinical and biochemical changes needed especially high doses of the vitamin (200 mg/day). Use of vitamin B6 in a dose of 100 mg/day in pyridoxine-dependent homocystinuria induced a remission of the biochemical parameters on the 4th day of the treatment. It is noted that the efficacy of the treatment is dependent on the timely starting of the therapy and pyridoxine doses necessary for normalization of the clinical and biochemical parameters in each patient.

摘要

讨论了维生素B6治疗遗传性代谢病患者的可能性。特别关注以吡哆醇需求量增加为特征的维生素B6依赖状况。在色氨酸代谢产物(黄尿酸和犬尿酸、犬尿氨酸、N1-甲基烟酰胺)和4-吡哆酸的肾脏排泄控制下,高剂量的吡哆醇成功用于治疗遗传性维生素B6依赖型黄尿酸尿症患者。追踪了疾病严重程度与所需吡哆醇剂量之间的相互关系。临床和生化变化最明显的患者尤其需要高剂量的维生素(200毫克/天)。在吡哆醇依赖型高胱氨酸尿症中,使用100毫克/天的维生素B6可在治疗第4天使生化指标缓解。值得注意的是,治疗效果取决于治疗的及时开始以及使每位患者临床和生化指标正常化所需的吡哆醇剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验